Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

Author： Dannon P.N. Sasson Y. Hirschmann S. Iancu I. Grunhaus L.J. Zohar J.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.10, Iss.3, 2000-05, pp. : 165-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

By Askari Neda

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 883-892

Adis International

Access to resources Recommend Favorite

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Preliminary, Single-Blind, Prospective Study

By Pallanti Stefano Bernardi Silvia Antonini Sarah

CNS Drugs, Vol. 23, Iss. 12, 2009-12 ,pp. : 1047-1055

Adis International

Access to resources Recommend Favorite

A Placebo controlled double blind study in obsessive compulsive disorder with fluvoxamine

By Kudo Y.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 371-372

Elsevier

Access to resources Recommend Favorite

Sequential administration of augmentation strategies in treatment-resistant obsessive compulsive disorder

By Blier P. Bergeron R. Heacute bert C.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 370-370

Elsevier

Access to resources Recommend Favorite

Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder

By Walsh Kelda H McDougle Christopher J

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2059-2067

Informa Healthcare

Access to resources Recommend Favorite